Publisher： Karger
E-ISSN： 2296-5262|28|4|177-178
ISSN： 2296-5270
Source： Oncology Research and Treatment, Vol.28, Iss.4, 2005-10, pp. : 177-178
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Testosterone therapy and cancer risk
BJU INTERNATIONAL, Vol. 115, Iss. 2, 2015-02 ,pp. :
Access to resources
Recommend
Lung cancer patients with an abnormal gene benefit from targeted therapy
CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. :
Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit
DIABETIC MEDICINE, Vol. 32, Iss. 3, 2015-03 ,pp. :
Molecular Markers in Gastrointestinal Cancer: Targeted Therapy and Tailored Chemotherapy
Oncology Research and Treatment, Vol. 27, Iss. 1, 2004-03 ,pp. :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. S3, 2015-09 ,pp. :